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Abstract
Several recent studies have highlighted the emergence of a globally disseminated clone of uropathogenic and invasive Escherichia coli iso-
lates of serotype O25:H4 and sequence type 131. The ability to characterize rapidly E. coli isolates of this lineage would facilitate
enhanced surveillance for this pathogen. We have used the semi-automated DiversiLab repetitive PCR-based system to analyse a collec-
tion of 35 clinical isolates of uropathogenic E. coli from across the UK, with particular focus on the O25:H4-ST131 lineage. All isolates
had been characterized using multilocus sequence typing (MLST), and 14 had previously been typed using pulsed-ﬁeld gel electrophoresis
(PFGE). The DiversiLab system allowed discrimination of O25:H4-ST131 isolates from those of other E. coli lineages. It was slightly
more discriminatory than MLST, but was less discriminatory than PFGE. With an analysis time of <4 h between receipt of a cultured
organism and provision of a typing result, the system offers information on a real-time basis, a major advantage over current practice.
We suggest that introduction of the DiversiLab system would be useful for rapid exclusion of E. coli isolates during outbreak investiga-
tions, and that the approach could be employed for surveillance for pathogenic or antibiotic-resistant clones of this organism.
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Introduction
Strains of Escherichia coli producing the CTX-M-15 extended-
spectrum b-lactamase (ESBL) enzyme have become the most
important type of ESBL-producing organisms causing urinary
tract infections in community and hospital settings in the UK
[1,2]. Their emergence constitutes a serious public health
concern that emphasizes the need for rapid and reliable epi-
demiological characterization of isolates and identiﬁcation of
outbreak/epidemic clones [1,3,4].
Numerous methods have been used previously to differ-
entiate and characterize E. coli, and each method has its
advantages and disadvantages [5], but pulsed-ﬁeld gel electro-
phoresis (PFGE) is currently one of the most widely used
methods in outbreak investigations, because of its high dis-
criminatory power [2]. Several published studies have shown
that multilocus sequence typing (MLST) is a useful tool for
population biology and long-term or global epidemiological
studies for a wide range of pathogens, including uropatho-
genic E. coli (UPEC) [3,6–10]. More recently, the use of
MLST has revealed a globally disseminated clone of UPEC
of sequence type (ST) 131, which is a signiﬁcant cause of
urinary tract infection and invasive infection in the UK,
Europe, Asia, and Canada [6,7,11–13]. Members of this clone
are of serotype O25:H4, are often resistant to ﬂuoroquinol-
ones, and frequently produce a CTX-M-15 b-lactamase,
although a recent report documented the occurrence of this
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strain in Europe with only four of 35 isolates expressing the
CTX-M-15 enzyme [13]. Rarely, members of this lineage also
produce a CMY-2-like AmpC enzyme [13,14]. CTX-M-15
ESBL-producing E. coli UK epidemic strains A–E[2] have
recently been shown to belong to the ST131 lineage [15],
emphasizing the importance of the clone in the UK.
Repetitive sequence-based PCR (Rep-PCR) is based on
ampliﬁcation of non-coding repetitive DNA sequences inter-
spersed throughout the genome [16]. During PCR, multiple
DNA amplicons of different sizes are generated to produce
a unique Rep-PCR proﬁle for each bacterial strain. Differ-
ences in these Rep-PCR proﬁles can be used to distinguish
among strains [16]. Several studies have used manual Rep-
PCR methods for typing ESBL-producing E. coli [17] and
verocytotoxin-producing E. coli O157 [18], although lack of
standardization can lead to difﬁculties in data interpretation
and interlaboratory comparisons.
A standardized, semi-automated Rep-PCR system, Diver-
siLab (bioMe´rieux, Basingstoke, UK), which uses microﬂui-
dic separation of PCR products, is now commercially
available [19]. The approach has been successfully used to
distinguish among strains of different organisms, such as
Acinetobacter spp. [20], methicillin-resistant Staphylococcus
aureus [21,22], Staphylococcus epidermidis [23], vancomycin-
resistant Enterococcus spp. [24,25], Clostridium difﬁcile [26],
Salmonella [27], Mycobacterium spp. [28], and fungi [29].
These studies have shown that the DiversiLab system is a
valuable tool for rapidly identifying the source of infection
and tracking its spread, and suggest that the approach
could be used to improve patient management and reduce
the costs associated with treatment, contamination, and
decontamination [19].
In the current study, a collection of well-characterized
UPEC strains, including strains of the O25:H4-ST131 lineage
with different antibiotic resistance phenotypes, were analysed
using the DiversiLab system.
Materials and Methods
Bacterial isolates
Thirty-ﬁve UPEC isolates that had been previously typed
using MLST [7], including a subcollection that had also been
previously analysed by PFGE (N. Woodford, M.E. Kaufmann,
A.J. Fox, M. Upton, unpublished data), were used to evaluate
the DiversiLab system. The collection comprised 20 CTX-M
ESBL producers, three isolates producing both CTX-M ESBLs
and CMY-2-like AmpC enzymes, two that were ESBL-nega-
tive but CMY-2-like AmpC-positive, and ten cephalosporin-
susceptible isolates. The isolates included representatives of
ﬁve PFGE-deﬁned UK epidemic strains (A–E) [2] and isolates
from hospitals in the North West region of England.
The isolates were cultured on Columbia agar plates (Oxoid,
Basingstoke, UK) by incubation for 18 h at 37C.
DNA extraction
A loopful of colonial growth was used for DNA extraction
with the UltraClean Microbial DNA isolation kit (Mo Bio
Laboratories, Carlsbad, CA, USA), according to the manufac-
turer’s instructions. The concentration of DNA was mea-
sured with an ND-1000 spectrophotometer (NanoDrop;
Agilent Technologies Inc., Santa Clara, CA, USA) and was
diluted to a working concentration of 25–50 ng/lL.
Rep-PCR ampliﬁcation
The DiversiLab Escherichia DNA Fingerprinting Kit (bio-
Merieux, Inc., Basingstoke, UK) was used for Rep-PCR ampli-
ﬁcation of non-coding intergenic repetitive elements in the
genomic DNA. The kit included Rep-PCR master mix 1, pri-
mer mix J, and kit-speciﬁc positive and negative controls.
Ampliﬁcation reactions were carried out in 25-lL reaction
volumes containing 2 lL of DNA (approximately 25–50 ng/lL
of DNA), 18 lL of Rep-PCR master mix 1, 2 lL of primer
mix J, 2.5 lL of GeneAmp 10· PCR buffer (ABI), and 0.5 lL of
AmpliTaq DNA polymerase (Applied Biosystems, Warrington,
UK).
The Rep-PCR reactions were carried out using an Eppen-
dorf thermal cycler (Mastercycler; Helena Biosciences, Gates-
head, UK), and the conditions included an initial denaturation
at 94C for 2 min and 35 cycles of the following: denaturation
at 94C for 30 s; annealing at 50C for 30 s; extension at 72C
for 90 s; and a ﬁnal extension at 72C for 3 min. The kit-
speciﬁc positive and negative controls were run together with
each set of reactions for validation of ampliﬁcation.
Separation of Rep-PCR ampliﬁcation products
Rep-PCR products, mixed with a gel–dye matrix with inter-
calating ﬂuorescent dye, were detected using microﬂuidic
‘lab-on-chip’ technology, in which DNA fragments are sepa-
rated on the basis of their size. There were 13 sample wells
on each chip. Each sample well was loaded with 5 lL of
DNA marker and 1 lL of PCR product. The microﬂuidics
chip was placed on an Agilent 2100 bioanalyzer (Agilent),
and separation of the amplicon was carried out in <1 h.
Data analysis
The DNA proﬁles were automatically downloaded onto a
secure DiversiLab website dedicated to our laboratory,
where each chip went through a quality control step in
which only patterns with a ﬂuorescence intensity >100 units
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were analysed. Comparison of samples was performed with
the web-based DiversiLab software version 3.3.40 (bioMe´r-
ieux, Mercy l’Etoile, France), using the Pearson correlation
coefﬁcient to calculate pairwise similarities among all samples
tested, and the unweighted pair group method with arithme-
tic mean [30] was used to create dendrograms.
Reports were automatically generated, including the den-
drogram, similarity matrix, ‘electropherograms’, gel-like
images, scatter plot, and selectable demographic ﬁelds for
data interpretation. Data analysis was performed according
to the manufacturer’s guidelines. Relationships between Rep-
PCR proﬁles were designated as recommended by the manu-
facturer: different—three or more band differences (similar-
ity <95%); similar—one to two band differences (similarity
95–97%); and indistinguishable—no band differences (similar-
ity >97%).
Results
Characterization of E. coli isolates by Rep-PCR
ﬁngerprinting
With use of a similarity threshold of 95% (light grey line in
Fig. 1) to deﬁne clusters, Rep-PCR analysis allowed identiﬁca-
tion of 15 different clusters among the 35 E. coli isolates:
Rep-PCR proﬁles A–E, H, I, K, L, M, and O (one isolate
each); Rep-PCR proﬁle J (18 isolates); and Rep-PCR
proﬁles F, G, and N (two isolates each) (Fig. 1).
Rep-PCR proﬁle J constituted a major cluster, consisting of
18 isolates (>50% of the collection). Of these 18 isolates, 13
were assigned to Rep-PCR proﬁle J, with indistinguishable
Rep-PCR proﬁles, three isolates were of subtype Ja, as they
displayed proﬁles similar to Rep-PCR proﬁle J (differing by one
band with 97% similarity), and two isolates were of subtype Jb
(differing by two bands with <95% similarity; Fig.1). Two iso-
lates were assigned to Rep-PCR proﬁle F and Rep-PCR pro-
ﬁle Fa, respectively, as they shared >97% similarity with one
band difference. With the exception of proﬁle G (three iso-
lates) and proﬁle N (two isolates), the remaining Rep-PCR
proﬁles (A–E, H, I, K, L, M, and O) were unique (Fig. 1).
Comparison of Rep-PCR results with MLST
The 35 E. coli isolates were previously determined to repre-
sent 14 different STs, using MLST. Rep-PCR allowed distinc-
tion among different STs (Fig. 1). The majority (13/18) of
ST131 isolates clustered together on the dendrogram (Fig. 1)
and had Rep-PCR proﬁle J; three isolates assigned to pro-
ﬁle Ja and two assigned to proﬁle Jb were also of ST131, and
both proﬁles clustered with proﬁle J at >90% similarity (dark
grey line in Fig. 1).
The semi-automated Rep-PCR approach also allowed
discrimination within ST73, with two isolates assigned to
proﬁle G and one to proﬁle H. Two isolates of ST391 were
assigned to proﬁle N.
Comparison of Rep-PCR-based and PFGE-based
characterizations
Fourteen ST131 isolates had previously been subjected to
PFGE analysis. Rep-PCR allowed identiﬁcation of three clus-
ters for these cefpodoxime-resistant E. coli isolates, and
PFGE allowed further subdivision of these groupings (Fig. 1).
All isolates previously assigned to the CTX-M-producing UK
epidemic strains A–E and two with unique PFGE proﬁles
displayed Rep-PCR proﬁle J or Ja. The two isolates assigned
to Rep-PCR proﬁle Jb were from PFGE-characterized UK
epidemic strain B (isolates 28 and 29 in Fig. 1).
Discussion
The work presented here represents the ﬁrst evaluation of
the utility and discriminatory power of the semi-automated
DiversiLab system for typing E. coli isolates, with a particular
focus on isolates of the globally disseminated O25:H4-ST131
lineage, which often produce CTX-M-15 ESBL. In addition,
this is the ﬁrst time that the resolving power of the Diversi-
Lab system has been compared with that of MLST.
The DiversiLab system showed a slightly higher level of
discrimination than MLST, but was less discriminatory than
PFGE. In the latter respect, our ﬁndings are in agreement
with those of previous studies that have compared PFGE and
the DiversiLab system, where a higher level of discrimination
among S. aureus isolates was seen with PFGE [21,22].
In our hands, the DiversiLab rep-PCR method clustered
E. coli isolates into clonal lineages similar to those identiﬁed by
MLST. With the manufacturer’s suggested cut-off of 95%, sub-
clustering within ST131 and ST73 was apparent (Fig. 1). The
ST131 isolates with proﬁle Jb (PFGE proﬁle B) grouped with
the majority of ST131 isolates only if a cut-off of 90% was used,
and, at this level, clustering of ST73 isolates was observed with
those of ST95 isolates, and of ST648 with ST59.
As none of these STs are part of the same clonal
complex, the clustering at the 90% level does not correctly
represent the phylogenetic linkage of some of the isolates. A
cut-off of 90% resulted in clustering of isolates 4 and 5
of ST410 and ST88, respectively, which are part of clonal
complex 23.
Although PFGE allowed distinction among isolates that clus-
tered together when a 95% cut-off was used, we suggest that
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this level of discrimination should be used when analysing
UPEC isolates in an outbreak situation. At this level, closely
related isolates that are part of an outbreak should cluster
together and unrelated isolates could be excluded from
further analysis, in a real-time manner. It may be advisable to
attempt subsequently to discriminate within the putative
outbreak isolates using PFGE, or sequence determination of a
limited number of the loci used for MLST. This would allow
conﬁrmation of isolates that were included in the outbreak.
When applied to a collection of S. aureus isolates, the
DiversiLab system allowed correct assignment of isolates to
outbreak groupings when a cut-off value of 85% was used
[22]. Similarly to our ﬁndings, at this level, some unrelated
isolates were clustered with outbreak organisms [22], but
the authors stated that this would be preferable to missing
outbreak isolates in screening programmes. Use of such a
low cut-off value for UPEC would clearly lead to incorrect
clustering of isolates, and our ﬁndings support the previous
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FIG 1. Repetitive sequence-based PCR (Rep-
PCR) proﬁle analysis, and dendrogram show-
ing similarity among 35 Escherichia coli isolates
with gel image of Rep-PCR patterns, Rep-PCR
proﬁles, sequence types (STs), resistance
phenotype and pulsed-ﬁeld gel electrophoresis
(PFGE) type of selected isolates.
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suggestion that user-deﬁned cut-off values will need to be
established for each species to which the DiversiLab system
is applied [22].
Although clustering at 95% would separate organisms that
may be relatively closely related phylogenetically, as seen
here with isolates of ST131 and ST73, comparison of Rep-
PCR proﬁles with those in laboratory-speciﬁc databases or
other secure libraries would indicate the wider relationships
of isolates [21].
Analysis of a larger and genetically and geographically more
diverse strain collection may allow more deﬁnitive selection of
a cut-off value for clustering of E. coli strains, including ESBL
producers. In particular, it would be interesting to analyse a
collection of isolates of the O25:H4-ST131 lineage from across
Europe and beyond. Similarly, it would be worthwhile to ana-
lyse isolates from known clonal outbreaks.
We propose that the DiversiLab system offers several
advantages over current ﬁngerprinting methods used for dis-
crimination among E. coli strains (or isolates).
The technique is relatively simple and easy to perform,
has a rapid total turnaround time of approximately 1–2 days
(including isolate culture), and allows the generation of
results in ‘real time’, which is a deﬁnite advantage over PFGE
and MLST. The rapid supply of ﬁngerprinting data to infec-
tion control teams has clear cost implications regarding the
response to potential outbreaks, and this is possibly one of
the major beneﬁts of the DiversiLab system.
We agree with previous suggestions [20,22] that the Di-
versiLab system could be used as a rapid, ﬁrst-line ﬁnger-
printing tool for investigating outbreaks and healthcare-
associated infections, and suggest that it should be employed
for surveillance of clones of highly pathogenic or antibiotic-
resistant bacteria.
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